What was Regeneron Pharmaceuticals, Inc.'s revenue in 2024?

Regeneron Pharmaceuticals, Inc. reported $14.2B in revenue for fiscal year 2024. This represents a +8.3% change compared to 2023.

How did Regeneron Pharmaceuticals, Inc.'s revenue change from 2023 to 2024?

Regeneron Pharmaceuticals, Inc. revenue grew from $13.1B in 2023 to $14.2B in 2024, a change of 8.3%.

Was 2024 Regeneron Pharmaceuticals, Inc.'s best revenue year?

No. Regeneron Pharmaceuticals, Inc.'s highest recorded revenue year was 2025 at $14.3B. In 2024, Regeneron Pharmaceuticals, Inc. reported $14.2B.

What was Regeneron Pharmaceuticals, Inc.'s highest ever annual revenue?

Regeneron Pharmaceuticals, Inc.'s highest ever annual revenue was $14.3B recorded in fiscal year 2025.

Regeneron Pharmaceuticals, Inc. Revenue in 2024: $14.2B | CorpDigest

C

CorpDigest

Search companiesSearchK Contact

Regeneron Pharmaceuticals, Inc.

BiotechnologyFounded 1988- Updated July 2025

Reviewed by Swet Parvadiya

|

Last reviewed: July 2025

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.

CD

CorpDigest

Year	Revenue	Net Income	YoY Change
FY2025	$14.3B	$4.4B	+0.7%
FY2024	$14.2B	—	+8.3%
FY2023	$13.1B	—	—

Year	Revenue	Net Income	YoY Change
FY2025	$14.3B	$4.4B	+0.7%
FY2024	$14.2B	—	+8.3%
FY2023	$13.1B	—	—

Regeneron Pharmaceuticals, Inc. Revenue in 2024

Revenue by Year

Regeneron Pharmaceuticals, Inc. Annual Revenue History

Regeneron Pharmaceuticals, Inc. Revenue in 2024

Revenue by Year

Regeneron Pharmaceuticals, Inc. Annual Revenue History